Part of public health policy is determining the best use of funds – to save or protect the most lives with the fewest resources. With all the demands on health care from heart disease, diabetes, AIDS, and other types of cancer, the economics for Gardasil don’t add up.
It is not hard to hear about Gardasil… “In television advertisements, a cast of hip people in their 20s — artists, writers and professionals — describe why they got the shots, in the language of liberation, such as, “I chose to get vaccinated because my dreams don’t include cervical cancer.” The advertisements direct viewers to [...]
From: Chartbook on Trends in the Health of Americans Health, United States, 2005 Pap Smear A Pap smear is a microscopic examination of cells scraped from the cervix that is used to detect cancerous or precancerous conditions of the cervix and other medical conditions. If detected, precancerous conditions can be treated before they become malignant. [...]
Researchers and public health officials are FINALLY waking up, and stepping up, to ask tough questions about the cost effectiveness of administering a very expensive, and not thoroughly vetted vaccine to every girl and young woman in the free world. Is the use of Gardasil® as a preventive measure against cervical cancer, the correct utilization [...]
Follow The Money… Merck has a growing economic interest in Virginia. In December 2006, Merck announced it would invest $57 million to expand its Elkton, Va., plant to make Gardasil, helped by a $700,000 grant from a state economic development agency that is part of the executive branch. Two months later, Gov. Tim Kaine, who [...]
Opportunistic marketing isn’t new. Mass merchandising of tobacco products to minors delivered millions of “Hooked for Life” or at least until premature death ‘users” for BIG TOBACCO. With recent regulations that allegedly limited marketing tobacco to minors, rapacious advertising agencies and armies of mercenaries (lobbyists) have moved to a new, even more, profitable venue —BIG [...]
FINALLY! In June of 2006, my writing partner, Leslie Botha, and I, started writing articles cautioning women against the use of Gardasil® for girls and young women. We cited the limited nature of the clinical trials (the number, and ages of women tested) and the length of time from the clinical trials and the FDA [...]
In a previous Inconvenient Woman Blog entry we noted the death of 17 year old Jessica Ericzon, “an all-American teenager,” whose tragic death has been tied to the Merck vaccine Gardasil®. Jefferson County Medical Examiner Samuel Livingstone, reported Jessie’s death to the federal Vaccine Adverse Events Reporting System. Her family started the Jessica Ericzon Memorial [...]
FDA News FOR IMMEDIATE RELEASE May 28, 2008 Media Inquiries: Susan Cruzan, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Proposes New Rule to Provide Updated Information on the Use of Prescription Drugs and Biological Products during Pregnancy and Breast-feeding The U.S. Food and Drug Administration today proposed major revisions to the physician labeling for prescription drugs (including [...]
Is the HPV vaccine a victory for women’s health or the triumph of aggressive marketing? Canadian reporters struggle to shed light on a muddled debate that’s as much about business as it is about health. When federal Finance Minister Jim Flaherty announced $300 million in funding for a program to vaccinate girls and young women [...]
© 2002- An Inconvenient Woman. Site design and construction by Pleiades Publishing Services, Co.
Powered by Wordpress and based on the template design MyJournal Hypereal by 
BlogoSquare
